Holdings
NEXTBio Capital Management LP
As of Sep 30, 2026, NEXTBio Capital Management LP reported 22 positions worth US$208M. Largest: Protagonist Therapeutics, Inc., Shattuck Labs, Inc. and COMPASS Pathways Plc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Protagonist Therapeutics, Inc. | 219K | US$30.9M | no change | Sep 30, 2026 |
| Shattuck Labs, Inc. | 3.73M | US$25.4M | no change | Sep 30, 2026 |
| COMPASS Pathways Plc | 1.78M | US$22.1M | new | Sep 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 132K | US$12.5M | no change | Sep 30, 2026 |
| Vor Biopharma Inc. | 621K | US$11.8M | −268K | Sep 30, 2026 |
| Xenon Pharmaceuticals Inc. | 310K | US$11.5M | +127K | Sep 30, 2026 |
| Zenas BioPharma, Inc. | 427K | US$11.5M | no change | Sep 30, 2026 |
| Palvella Therapeutics, Inc. | 80,409 | US$11.1M | −9,500 | Sep 30, 2026 |
| Structure Therapeutics, Inc. | 312K | US$9.77M | new | Sep 30, 2026 |
| ORIC Pharmaceuticals, Inc. | 684K | US$9.22M | −21,648 | Sep 30, 2026 |